Jacques Servier, the billionaire founder of France’s second-largest drugmaker, Les Laboratoires Servier, who late in life faced accusations of hiding information about life-threatening risks caused by a diabetes drug his companies sold, has died. He was 92.
After Valeant Pharmaceuticals International Inc. bought Bausch & Lomb Inc. for $8.7 billion last year, Chief Executive Officer Mike Pearson discovered the budget for the eyecare company’s communications team was 13 times the size of his own.
GlaxoSmithKline Plc is pushing for more stringent regulation of electronic cigarettes, which compete with its Nicorette gum and other smoking cessation products, according to e-mails from a company executive.
House Republicans say a drugmaker- funded advertising campaign run by supposedly independent groups was part of an agreement with the Obama administration to help pass the U.S. health-care law in 2010.